A na-eji insulins ndị na-arụ ọrụ ogologo oge iji na-ejikwa homonụ na-ahụkarị na ụdị 1 na ụdị shuga 2. Ọgwụ ndị a gụnyere Tresiba nke Novo Nordisk mepụtara.
Tresiba bụ ọgwụ dabere na homonụ nke oke ugwu.
Ọ bụ analog ọhụụ nke insal insulin. Ọ na-enye otu njikwa glycemic ahụ nwere obere mbelata hypoglycemia.
Njirimara na mmeghachi ọgwụ
Njirimara nke ogwu gunyere:
- nkwụsi ike ma dị larịị na glucose;
- mee ihe karịrị awa 42;
- mgbanwe dị ala;
- mbelata shuga;
- ezigbo nchekwa profaịlụ;
- enwere ike gbanwee obere oge na nchịkwa nke insulin na-enweghị imebi ahụike.
A na - emepụta ọgwụ ahụ n'ụdị katridges - "Tresiba Penfil" yana sirinji-pen nke eji kaa akara cartridges - "Tresiba Flexstach". Ngwakọta ọrụ na-arụ ọrụ bụ insulin Degludec.
Degludec na-ejikọ mgbe nnabata nke abụba na akwara. A na-enweta nwayọ nwayọ na nwayọ na-abanye n'ọbara. N'ihi ya, a na-amatawanye mgbanye glucose ọbara.
Ọgwụ na-akwado nnabata nke glucose site n’akwara na igbochi ihe nzuzo ya na imeju. Site na mmụba nke usoro onunu ogwu, a na –ebelata mmịpụta shuga.
E mepụtara ịta ahụ homonụ na ọkara ka ejiri ụbọchị abụọ ejiri ya. Agwakọta nke ihe dị mkpa na-adịgide karịa awa iri anọ na anọ. Ọkara iwepu ọkara ndụ na-adị n'otu ụbọchị.
Ihe ngosi maka ojiji: oria 1 na oria abuo n’ime ndi okenye, oria shuga n’ime umuaka site na otu afo.
Ihe ndi mmadu na - eme ka anakpo insulin nke Tresib: nfụkasị ahu mejuputara ọgwụ ogwu, emekorita ogo Degludek.
Ntụziaka maka ojiji
Ọkacha mma ị drugụ ọgwụ ahụ n'otu oge. A na-anabata nnabata otu ugboro n'ụbọchị. Ndị ọrịa nwere ụdị oria 1 na-eji Degludec na mkpụkọ mkpụmkpụ iji gbochie ya ịdị mkpa n'oge nri.
Ndị ọrịa nwere ọrịa shuga na-a theụ ọgwụ na-enweghị aka maka ọgwụgwọ ọzọ. A na - enye Tresiba ma iche iche yana yana ọgwụ ndị nwere tebụl ma ọ bụ insulin ndị ọzọ. N'agbanyeghị ngbanwe ịhọrọ oge nchịkwa, obere oge kwesịrị ịdịkarịa ala elekere 8.
Ọ bụ dọkịta ka o doziri usoro insulin. A na-agbakọ ya dabere na mkpa nke onye ọrịa na homonụ na ntinye aka na nzaghachi glycemic. Usoro akwadoro bụ nkeji iri. Na mgbanwe na nri, ibu, a na-arụzi ya. Ọ bụrụ na onye nwere ọria ụdịrị shuga tookụrụ insulin ugboro abụọ n'ụbọchị, ego onye insulin na-elekọta ga-ekpebi n'otu n'otu.
Mgbe ị na-agbanye insulin nke Tresib, a na-achịkwa ike glucose ike. A na-elebara ndị na-egosi ihe anya na izu mbụ nke ntụgharị. A na-etinye otu ihe ruru otu isi site na usoro ị previousụ ọgwụ gara aga.
A na - agbanye Tresiba n'ime mpaghara ndị a: apata ụkwụ, ubu, mgbidi n'ihu nke afọ. Iji gbochie mmepe nke mgbakasị ahụ na ịrịọsi arịrịọ ike, ebe ahụ na-agbanwe kpam kpam n'otu mpaghara ahụ.
Amachibidoro ịhazi homonụ n'ime intraven. Nke a na-akpalite oke hypoglycemia. Ejighi ọgwụ ahụ na pumps na intramuscularly. Nchịkwa ikpeazụ nwere ike ịgbanwe ọnụego nnabata.
Ntụziaka vidiyo maka iji sirinji dee:
Mmetụta akụkụ na ị andụbiga mmanya ókè
N'ime nsogbu mmeghachi omume na ndị ọrịa na-ewere Tresiba, a hụrụ ihe ndị a:
- hypoglycemia - ọtụtụ mgbe;
- lipodystrophy;
- ọgbụgba;
- mmeghachi omume akpụkpọ ahụ nfụkasị;
- mmeghachi omume na saịtị ịgba ahụ;
- mmepe nke retinopathy.
N'ime usoro ị theụ ọgwụ ahụ, hypoglycemia nke ogo dị iche iche nwere ike ime. A na - eme usoro dịgasị iche iche dabere n'ọnọdụ ahụ.
Site na mbelata nke glycemia, onye ọrịa na-a sugarụ shuga 20 g ma ọ bụ ngwaahịa ndị nwere afọ ojuju. A na-atụ aro ka ị na-ebu glucose oge niile.
Na ọnọdụ siri ike, nke jikọtara na mwepu mmụọ, IM glucagon ewebata. N'ọnọdụ na-agbanweghi agbanwe, a na-ewebata glucose. A na-enyocha onye ọrịa ahụ ruo ọtụtụ awa. Iji wepu nlọghachi, onye ọrịa na-eri nri carbohydrate.
Ndị Ọrịa na Nduzi Pụrụ Iche
Ihe omuma banyere iwere ogwu ahu n’ime otu ndi oria puru iche:
- Anabatara Tresiba ka ndị agadi jiri ya. Otu a nke ndị ọrịa kwesịrị inyocha ọkwa shuga ọtụtụ oge.
- Enweghị ọmụmụ ọ bụla na nsonaazụ ọgwụ ahụ n'oge afọ ime. Ọ bụrụ n’ikpebie ị takeụ ọgwụ ahụ, a na-atụ aro ka enwekwu nleba anya nke ndị na - egosi ya, ọkachasị n’oge nke abụọ na nke atọ.
- Enweghị data ọ bụla na nsonaazụ ọgwụ ahụ n'oge a na-enye nwa ara. N'ime usoro inye ụmụ ọhụrụ nri, a hụrụ ihe ndị na-adịghị mma.
Mgbe ị na-a ,ụ, a na-atụle njikọta nke Degludek yana ọgwụ ndị ọzọ.
Anabolic steroid, ACE inhibitors, sulfonamides, ihe mgbochi adrenergic, salicylates, ọgwụ ndị na-ebelata shuga, ndị na-egbochi MAO belata ọkwa shuga.
Ọgwụ na -emewanye mkpa maka homonụ gụnyere sympathomimetics, glucocorticosteroids, Danazole.
Mmanya na-egbu egbu nwere ike imetụta ihe omume Degludek ma na ntinye aka na ibelata ọrụ ya. Site na njikọta nke Tresib na Pioglitazone, nkụda obi, ọzịza nwere ike ịmalite. Ndị ọrịa nọ n'okpuru nlekọta nke dibịa n'oge ọgwụgwọ. N'ihe gbasara ọrụ obi ike, a na-akwụsị ọgwụ ahụ.
Na ọrịa nke imeju na akụrụ n'oge ịgwọ insulin, a ga-ahọrọ nhọrọ nke otu onye. Ndị ọrịa kwesịrị ijikwa shuga ugboro ugboro. Na ọrịa na-efe efe, nsị nke thyroid, nrụgide akwara, mkpa maka mgbanwe usoro onunu ogwu dị mma.
Ọgwụ nwere mmetụta yiri nke ahụ, mana ya nwere ihe dị iche na-arụ ọrụ, gụnyere Aylar, Lantus, Tujeo (insulin Glargin) na Levemir (insulin Detemir).
Na ule nnwale nke Tresib na ọgwụ ndị yiri ya, ha kpebiri otu arụmọrụ. N'oge ọmụmụ ihe ahụ, enwere ụbara shuga na mberede, ntakịrị ntakịrị hypoglycemia nke ehihie.
Akaebe nke ndị ọrịa shuga na-abụkwa ihe akaebe nke ịdị irè na nchekwa nke Treshiba. Ndị mmadụ na-ahụ maka ịdị mma nke ọgwụ ahụ. N'etiti nsogbu ndị ahụ, a na-egosipụta ọnụahịa dị elu nke Degludek.
Enwere m ọrịa shuga kemgbe ihe karịrị afọ iri. Na nso nso a agbanwuru m Tresibu - nsonaazụ ya dị oke mma ogologo oge. Ọgwụ a na-agbadata ọfụma na ọfụma karịa Lantus na Levemir. M tetara n'ụra shuga nkịtị n'ụtụtụ echi ya. Enwebeghị ụdị hypoglycemia nke ehihie. Naanị "mana" bụ ọnụahịa dị elu. Ọ bụrụ na ego enyere, ọ ka mma ịgbanye ọgwụ a.
Oksana Stepanova, 38 afọ, St. Petersburg
Tresiba bụ ọgwụ na-enye ọgwụ insulin. Nwere profaịlụ nchekwa dị mma, na-ebelata shuga. Nyocha ndị ọrịa na-akwado ịdị irè ya na nkwụsi ike ya. Ọnụ ahịa insulin Tresib dị ihe dị ka 6000 rubles.
